On 21 April 2026, Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (“Fosun Pharma”) announced that its 2025 Environmental, Social and Governance (ESG) and Sustainability Report is now available in both English and Chinese on the company’s website (www.fosunpharma.com) and on HKEX’s disclosure platform (www.hkexnews.hk).
Shareholders unable to access the online document may obtain a complimentary printed copy by submitting a signed written request to the H-share registrar, Tricor Investor Services Limited, at 17/F, Far East Finance Centre, 16 Harcourt Road, Hong Kong.
Further enquiries can be directed to the registrar’s hotline at +852 2980 1333, Monday to Friday, 9:00 a.m. to 6:00 p.m., excluding public holidays.
The notice was issued under the authority of Chairman Chen Yuqing.
Comments